⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Mirae Asset Large & Midcap Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | — | HDFC MF |
| Category | Equity - Large & Mid Cap Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹166.95 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★ | ★★★★★ |
| Benchmark | NIFTY LargeMidcap 250 - TRI | BSE Health Care - TRI |
| Fund Manager | Neelesh Surana | Nikhil Mathur |
| Inception | 01 Jan 2013 | 04 Oct 2023 |
| Returns | ||
| 1Y | -6.15% | 22.64% |
| 3Y | 11.41% | 30.41% |
| 5Y | 9.29% | — |
| Since Inception | 19.61% | 29.15% |
| Risk | ||
| 14.42 | 14.07 | |
| 0.99 | 0.59 | |
| 0.37 | 1.59 | |
| 0.05 | 21.67 | |
| 0.65 | 3.48 | |
| -11.91% | -9.23% | |
| Costs | ||
| Expense Ratio | 0.85% | 1.03% |
| Exit Load | 1% on or before 1Y(365D), Nil after 1Y(365D) | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹99 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Mirae Asset L…97%
HDFC MF97%
3.4%Only 3.4% of holdings by weight are common between Mirae Asset Large & Midcap Fund - Growth - Direct Plan and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingMirae Asset Large & Midcap Fund - Growth - Direct PlanHDFC MF
Lupin Ltd.1.87%3.55%
Divi's Laboratories Ltd.1.52%9.39%
Category context: Equity vs Equity. Open the full Screener →